article thumbnail

Digital therapeutics startup Neuroglee raises $10M to help people with neurodegenerative conditions

TechCrunch

Neuroglee Therapeutics , a startup developing digital therapeutics for people with neurodegenerative diseases, has raised a $10 million Series A led by Openspace Ventures and EDBI. million to develop digital therapeutics for neurodegenerative diseases. Venture investing in elder tech. Neuroglee gets $2.3

article thumbnail

The growing power of digital healthcare: 6 trends to watch in 2022

TechCrunch

GHI Fund President Bill Taranto has spent more than two decades in the healthcare industry and has 15 years of experience in healthcare investing. In addition to his venture investing knowledge, Bill has decades of management operations experience. 4 strategies for building a digital health unicorn. Share on Twitter.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

6 questions investors should ask when evaluating psychedelic biotech companies

TechCrunch

As a venture firm that invests in psychedelics, we receive hundreds of pitches every month from founders developing psychedelic therapeutics. Our fund has invested more than $15 million in companies developing psychedelic therapeutics. So how do we pick which companies to invest in? Greg Kubin. Contributor.

article thumbnail

metaMe Health Raises $2.2M in Funding

HPA

We’re excited to share that metaMe Health , a prescription digital therapeutics (PDT) company, today announced raising $2.2M in funding. HPA led the round , which will help metaMe continue its preparations for Regulora’s market launch and the build out of metaMe’s commercial infrastructure.

health 113
article thumbnail

MedRhythms raises $25M to get patients back in tune after a stroke

TechCrunch

MedRhythms secured $25 million in Series B funding to advance its digital therapy platform aimed at measuring and improving someone’s ability to walk after they have experienced a neurologic injury or disease. A year ago, MedRhythms’ digital therapeutic product received Breakthrough Device designation from the U.S.

article thumbnail

Atommerce wants to scale its mental health platform with $16.7M funding

TechCrunch

With the recent funding, Atommerce plans to enhance artificial intelligence and machine learning technology for its platform and invest in digital therapeutics specialized in mental illness. The Series B was led by Hashed, with participation from E&Investment, K2 Investment, and Samsung Next.

health 83
article thumbnail

metaMe Health Raises $2.2M in Funding

HPA

We’re excited to share that metaMe Health , a prescription digital therapeutics (PDT) company, today announced raising $2.2M in funding. HPA led the round , which will help metaMe continue its preparations for Regulora’s market launch and the build out of metaMe’s commercial infrastructure.

health 91